HHLR ADVISORS, LTD.
13F Holdings and Portfolio Analysis
Zhang Lei 2024 Q2 13F holdings, quarterly changes, portfolio value trend and position weight distribution.
HHLR ADVISORS, LTD. Overview
HHLR ADVISORS, LTD. held 78 stocks in 2024 Q2, with total market value around $4.05B.
HHLR ADVISORS, LTD.'s top five holdings in 2024 Q2: PDD HOLDINGS INC COMMON STOCK(PDD) 29.16%, BeOne Medicines AG(ONC) 18.22%, Alibaba Group Holding Limited(BABA) 9.55%, KE Holdings Inc.(BEKE) 8.09%, Legend Biotech Corporation(LEGN) 7.25%.
- Portfolio Value
- $4.05B
- Current Holdings
- 78 stocks
- New / Increased
- 25 / 17
- Reduced / Exited
- 16 / 10
Current Holdings
| 1 | PDD HOLDINGS INC COMMON STOCKPDD | 1.18 | 29.16% | 8.89 -24.59% | $132.95 | $88.14 -33.70% | $96.79 | -2.90 | 2.25 | -$0.08B-8.94% | Reduced |
| 2 | BeOne Medicines AGONC | 0.74 | 18.22% | 5.18 - | $142.67 | $316.42 +121.78% | $136.90 | 0.00 | 5.75 | +$0.93B+131.14% | Held |
| 3 | Alibaba Group Holding LimitedBABA | 0.39 | 9.55% | 5.38 +3638.32% | $72.00 | $125.39 +74.15% | $72.82 | +5.24 | 2.25 | +$0.28B+72.20% | Increased |
| 4 | KE Holdings Inc.BEKE | 0.33 | 8.09% | 23.17 -20.59% | $14.15 | $18.29 +29.26% | $18.23 | -6.01 | 4.00 | +$0.00B+0.35% | Reduced |
| 5 | Legend Biotech CorporationLEGN | 0.29 | 7.25% | 6.64 +10.89% | $44.29 | $31.96 -27.84% | $67.42 | +0.65 | 4.25 | -$0.24B-52.59% | Increased |
| 6 | Vipshop Holdings LimitedVIPS | 0.19 | 4.76% | 14.81 +7355.19% | $13.02 | $14.22 +9.22% | $12.93 | +14.61 | 3.50 | +$0.02B+9.96% | Increased |
| 7 | NetEase, Inc.NTES | 0.13 | 3.27% | 1.39 +825.73% | $95.58 | $149.02 +55.91% | $93.10 | +1.24 | 1.75 | +$0.08B+60.06% | Increased |
| 8 | ArriVent BioPharma, Inc.AVBP | 0.08 | 2.05% | 4.48 +14.14% | $18.55 | $19.51 +5.18% | $17.95 | +0.56 | 0.50 | +$0.01B+8.72% | Increased |
| 9 | TRIP COM GROUP LTDTCOM | 0.07 | 1.61% | 1.38 | $47.00 | $48.30 +2.77% | $47.00 | +1.38 | 0.25 | +$0.00B+2.77% | New |
| 10 | KINIKSA PHARMACEUTICALS INTLCUSIP G52694109 | 0.06 | 1.45% | 3.14 | $18.67 | - | $18.67 | +3.14 | 0.25 | $0.00B0.00% | New |
| 11 | FUTU HOLDINGS LTDFUTU | 0.05 | 1.16% | 0.72 | $65.61 | $103.30 +57.46% | $65.61 | +0.72 | 0.25 | +$0.03B+57.46% | New |
| 12 | ENFUSION INCENFN | 0.04 | 1.05% | 4.98 - | $8.52 | - | $20.94 | 0.00 | 2.75 | -$0.06B-59.31% | Held |
| 13 | Cytek Biosciences, Inc.CTKB | 0.04 | 0.92% | 6.66 - | $5.58 | $3.95 -29.21% | $21.41 | 0.00 | 3.00 | -$0.12B-81.55% | Held |
| 14 | BridgeBio Pharma, Inc.BBIO | 0.04 | 0.87% | 1.39 +1.69% | $25.33 | $54.92 +116.82% | $40.26 | +0.02 | 5.25 | +$0.02B+36.42% | Increased |
| 15 | Danaher CorporationDHR | 0.03 | 0.67% | 0.11 -76.93% | $249.85 | $178.12 -28.71% | $232.91 | -0.36 | 1.25 | -$0.01B-23.52% | Reduced |
| 16 | DoorDash, Inc.DASH | 0.03 | 0.67% | 0.25 -57.51% | $108.78 | $154.61 +42.13% | $50.74 | -0.34 | 3.75 | +$0.03B+204.68% | Reduced |
| 17 | Salesforce, Inc.CRM | 0.02 | 0.61% | 0.10 -79.15% | $257.10 | $210.90 -17.97% | $207.81 | -0.37 | 4.50 | +$0.00B+1.48% | Reduced |
| 18 | Meta Platforms, Inc.META | 0.02 | 0.55% | 0.04 +641.27% | $504.22 | $612.96 +21.57% | $501.71 | +0.04 | 0.50 | +$0.00B+22.18% | Increased |
| 19 | AstraZeneca PLCAZN | 0.02 | 0.52% | 0.27 | $77.99 | $84.69 +8.59% | $77.99 | +0.27 | 0.25 | +$0.00B+8.59% | New |
| 20 | H World Group LimitedHTHT | 0.02 | 0.47% | 0.57 -39.25% | $33.32 | $37.79 +13.42% | $47.28 | -0.37 | 4.25 | -$0.01B-20.07% | Reduced |
| 21 | YATSEN HLDG LTD SPONSORED ADSYSG | 0.02 | 0.46% | 6.99 - | $2.66 | - | $2.11 | 0.00 | 0.50 | +$0.00B+26.07% | Held |
| 22 | AppLovin CorporationAPP | 0.02 | 0.45% | 0.22 +66.97% | $83.22 | $570.99 +586.12% | $74.84 | +0.09 | 0.50 | +$0.11B+662.99% | Increased |
| 23 | On Holding AGONON | 0.02 | 0.39% | 0.41 - | $38.80 | $41.82 +7.78% | $30.13 | 0.00 | 3.00 | +$0.00B+38.80% | Held |
| 24 | ALPHABET INC CAP STK CL CGOOG | 0.01 | 0.32% | 0.07 +18.38% | $183.42 | $371.98 +102.80% | $157.10 | +0.01 | 0.50 | +$0.01B+136.78% | Increased |
| 25 | Geron CorporationGERN | 0.01 | 0.31% | 2.99 | $4.24 | $1.20 -71.70% | $4.24 | +2.99 | 0.25 | -$0.01B-71.70% | New |
Showing 1-25 of 78
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis is an estimate and can differ materially from the actual cost, especially in edge cases.
Cost basis estimate: from the latest uninterrupted holding period, new or increased shares are added to the cost pool at the report price; reductions remove shares at the then-average cost. Example: buy 100 shares at $10 in Q1 and add 50 shares at $16 in Q2, estimated cost basis is (100 x 10 + 50 x 16) / 150 = $12 per share.
Return shows estimated dollar return on top and percentage return below. It uses current price when available, otherwise report price.
Exited Holdings
Stocks no longer disclosed in the current 13F portfolio for 2024 Q2.
| 1 | Advanced Micro Devices, Inc.AMD | 0.91 | 0.25 | $180.49 | $180.49 | $0.00B0.00% |
| 2 | Take-Two Interactive Software, Inc.TTWO | 0.78 | 1.00 | $147.16 | $155.49 | +$0.01B+5.66% |
| 3 | Kiniksa Pharmaceuticals International, plcKNSA | 3.14 | 0.25 | $19.73 | $19.73 | $0.00B0.00% |
| 4 | BAIDU INC - SPON ADRBIDU | 0.15 | 1.25 | $147.19 | $86.48 | -$0.01B-41.24% |
| 5 | Mondelez International, Inc.MDLZ | 0.20 | 5.50 | $40.03 | $67.84 | +$0.01B+69.47% |
| 6 | Marvell Technology, Inc.MRVL | 0.06 | 0.25 | $70.88 | $70.88 | $0.00B0.00% |
| 7 | Vertiv Holdings CoVRT | 0.04 | 0.25 | $81.67 | $81.67 | $0.00B0.00% |
| 8 | Atour Lifestyle Holdings LimitedATAT | 0.05 | 1.50 | $12.07 | $18.35 | +$0.00B+51.99% |
| 9 | FULL TRUCK ALLIANCE CO LTDYMM | 0.01 | 2.25 | $14.04 | $8.04 | -$0.00B-42.74% |
| 10 | Constellation Energy CorporationCEG | 0.00 | 0.25 | $184.85 | $200.27 | +$0.00B+8.34% |
Showing 1-10 of 10
Exited holdings are stocks disclosed in the previous report period but no longer disclosed in the current 13F portfolio.
"Holding Period (yrs)" is the latest uninterrupted holding duration, calculated by dividing continuous reported quarters by 4.
Cost basis uses the same weighted cost-pool method as current holdings. Estimated exit price uses the current report period weighted report price when available, otherwise the previous report price; it does not represent the actual sale price.
Exit return shows estimated dollar return on top and percentage return below.
Portfolio Visuals
Track portfolio value, position weights and Top 10 history.